Feed Subscription (more)

American Cancer Center Online

syndicated content boosted by feedcat.net

Show Feed as XML

 

Current Feed Content from 5 Oct 08 04:04

• Cancer: Questions and Answers

  Sep 21, 2006 17:02
  Cancer is the second leading cause of death in this country. However, improvements in cancer detection, diagnosis, and treatment have increased the survival rate for many types of cancer.

• Asbestos Exposure: Questions and Answers

  Sep 19, 2006 21:44
  Nearly everyone is exposed to asbestos at some time during their life. However, most people do not become ill from their exposure. People who become ill from asbestos are usually those who are exposed to it on a regular basis.

• Common Cancer Types

  Sep 17, 2006 10:31
  The list of common cancers includes cancers that are diagnosed with the greatest frequency in the United States. Cancer incidence statistics from the American Cancer Society and other resources were used to create the list.

• Vitamin C Injections Slow Tumor Growth in Mice

  Aug 27, 2008 13:34
  Injecting high doses of vitamin C into mice with aggressive cancers slowed the growth of their tumors significantly without affecting normal tissues, researchers are reporting.
  National Cancer Institute

• Suicide Risk Higher in Cancer Patients than the General Population

  Aug 27, 2008 13:32
  The incidence of suicide among U.S. cancer patients is nearly twice that of the general population, and suicide rates vary among patients with cancers of different anatomic sites.
  National Cancer Institute

• Cord-Blood Transplant into Bone Restores Blood Counts

  Aug 27, 2008 13:30
  In a preliminary clinical trial, most patients with acute leukemia who received a cord-blood stem cell transplant through an injection directly into the iliac crest of the pelvic bone, experienced complete hematologic recovery within an average of 36 days.
  National Cancer Institute

• Breast Cancer Relapse Risk Low after Chemotherapy or Tamoxifen

  Aug 27, 2008 13:29
  Relatively few breast cancer survivors who are disease-free for 5 years after starting a systemic adjuvant therapy such as chemotherapy or tamoxifen experience a recurrence, but preventive treatments are needed to reduce the relapse rate further.
  National Cancer Institute

• Alternative Vaccine Strategy Shows Promise in Prostate Cancer Patients

  Aug 27, 2008 13:24
  New research indicates that giving patients a continuous low dose of an immune system booster is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients.
  National Cancer Institute

• New Research Results Explain How Dormant Tumor Cells Become Active in Later Years

  Aug 12, 2008 16:02
  Scientists using a three-dimensional cell culture system have identified a mechanism by which dormant, metastatic tumor cells can begin growing again after long periods of inactivity.
  NCI

• Panel Recommends Against PSA Testing in Men 75 or Older

  Aug 12, 2008 15:57
  In updated recommendations released today, the U.S. Preventive Services Task Force (USPSTF) is advising against the routine use of prostate-specific antigen (PSA) testing to screen for prostate cancer in men age 75 and older.
  NCI

• Billionaires Boost Global Fight Against Tobacco

  Aug 12, 2008 15:54
  The Bill and Melinda Gates Foundation funds will be used to build economic evidence to support tobacco control and to educate the public about the harmful effects of tobacco.

• Nanoparticles Deliver Chemotherapy and Block Cancer's Spread

  Jul 24, 2008 11:22
  By using targeted nanoparticles carrying significantly reduced doses of chemotherapy, researchers have demonstrated the ability to preferentially block the spread of cancer, while largely sparing the surrounding tissues.

• Fewer Americans Exposed to Secondhand Smoke

  Jul 24, 2008 11:21
  The prevalence of self-reported secondhand smoke (SHS) exposure at home and changes in any exposure declined significantly in nonsmoking children, adolescents, and adults in recent years.

• Yeast-Based Vaccine Induces Immune Responses and Reduces Tumor Size in Mice

  Jul 24, 2008 11:19
  Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice.
  NCI

• Study Shows That Small Protein Can Broaden Immune Response in Humans

  Jul 24, 2008 11:03
  Treating cancer patients with interleukin-7 (IL-7), a small protein that can stimulate the immune system, leads to an increase in lymphocytes which are key to the production of effective immune responses in the body.
  NCI

• Beth Robertson of Tampa Florida has committed to walk and has agreed to raise a minimum of $2, 200 to help fight breast cancer

  Jul 19, 2008 08:56
  The Breast Cancer 3-Day is a weekend of hope, as we honor lives lost, celebrate survivors, promote breast cancer research and help bring breast cancer care to those who so desperately need it.
  Beth Robertson

• Mouse Studies Identify Gene that May Influence Metastasis Risk in Breast Cancer

  Apr 23, 2008 14:12
  Researchers have identified a pattern of gene activity in mice that may help to predict individual risk for breast cancer metastasis and survival in humans.
  NCI

• Elderly Medicaid Patients Less Likely to Receive Chemotherapy for Colorectal Cancer

  Mar 28, 2008 15:39
  A study using data from the Michigan Tumor Registry and the Centers for Medicare and Medicaid Services showed that elderly Medicaid-insured patients in the state are less likely to initiate or complete chemotherapy for colorectal cancer compared with Medicare-insured patients.
  NCI

• Protein May Control Spread of Breast Cancer

  Mar 28, 2008 15:38
  A single protein may trigger the spread of breast cancer cells to other parts of the body by altering the behavior of large numbers of genes.
  NCI

• Delayed Letrozole Therapy After Tamoxifen Reduces Breast Cancer Recurrence

  Mar 28, 2008 15:34
  An analysis of data from a phase III clinical trial indicates that in some breast cancer patients, use of the aromatase inhibitor letrozole after 5 years of adjuvant therapy with tamoxifen has survival benefits even if begun several years after completing tamoxifen.
  NCI

feedcat.net promotes your content, measures audiences
and saving load of your server resources!

Start feed boosting now for free.

*